Medical News

Surgery

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Merchant NB et al. – Study demonstrates that the benefit of adjuvant chemoradiation therapy (CRT) is seen only in those patients with pancreas adenocarcinoma that have lymph node (LN)-positive disease, regardless of resection margin status. CRT in LN-negative disease may contribute to reduced disease-free survival.

Methods

Results